Lilly and Banner Alzheimer’s Institute in strategic research collaboration for donanemab trial

Lilly and Banner Alzheimer’s Institute in strategic research collaboration for donanemab trial

Submitted by admin on July 15, 2021 - 12:27pm
Source: 
Biopharma Reporter
News Tags: 
Eli Lilly
Banner Alzheimer's Institute
donanemab
clinical trials
Alzheimer's disease
Headline: 
Lilly and Banner Alzheimer’s Institute in strategic research collaboration for donanemab trial
snippet: 

Eli Lilly and Company and Banner Alzheimer’s Institute have announced a strategic research collaboration as part of the planned Phase 3 study for donanemab in participants at risk from cognitive and functional d

Do Not Allow Advertisers to Use My Personal information